(See all Suresh Joshi's publications in PubMed.)
"Involvement of multiple stressors induced by non-thermal plasma-charged aerosols during inactivation of airborne bacteria"
Vaze ND, Park S, Brooks AD, Fridman A, Joshi SG
PLOS ONE 12(2): e0171434 (2017)
"Atherosclerosis: the novel finding of biofilms and innate immune system activity within the plaques"
Allen HB, Boles J, Morales D, Ballal S, Joshi SG
Journal of Medical and Surgical Pathology 1(4): 135-140 (2016)
"Chemical Changes in Nonthermal Plasma-Treated N-Acetylcysteine (NAC) Solution and Their Contribution in Bacterial Inactivation"
Ercan UK. Smith J, Ji H-F, Brooks AD, Joshi SG
The Scientific Reports 6:20365, doi:10.1038/srep20365 (2016)
"Autoimmune Diseases of the Innate and Adaptive Immune System Including Atopic Dermatitis, Psoriasis, Chronic Arthritis, Lyme Diseases, and Alzheimer’s Disease"
Allen HB, Shaver CM, Etzler CA, Joshi SG
Immunochemistry and Immunopathology 1(2): 112 (2015)
“Studies on Acinetobacter baumannii involving multiple mechanisms of carbapenem resistance"
Sen B, Joshi SG
Journal of Applied Microbiology (2015)
“Phenotypic ESBL Detection in Acinetobacter baumannii: A Real Challenge” [PDF]
Litake GM, Ghole VS, Niphadkar KB, Joshi SG
American Journal of Infectious Diseases 11(3): 48-53, DOI: 10.3844/ajidsp.2015.48.53 (2015)
"Microarray analysis of transcriptomic response of Escherichia coli to nonthermal plasma-treated PBS solution"
Joshi SG, Yost A, Joshi SS, Addya S, Ehrlich GD, Brooks AD.
Advances in Bioscience and Biotechnology 6(2): 49-62 (2015)
"Inhibition of biofilms by non-thermal plasma treated novel solutions"
Ercan UK, Joshi SS, Yost A, Gogotsi N, O'Toole S, Paff M, Melchior E, Joshi SG.
Advances in Microbiology 4(16): 1188-1196 (2014)
"Calcium binding-mediated sustained release of minocycline from hydrophilic coatings targeting infection and inflammation"
Zhang Z, Nix CA, Ercan UK, Gerstenhaber JA, Joshi SG, Zhong Y.
PLoS One 9(1): e84360-68 (2014)
"The presence and impact of biofilm-producing staphylococci in atopic dermatitis"
Allen HB, Vaze NS, Choi C, Hailu T, Cusack CA, Joshi SG.
JAMA Dermatology, published online; doi:10.1001/jamadermatol.2013.8627 (Jan 22 , 2014)
"Patient demographics and characteristics of infection with carbapenem-resistant Acinetobacter baumannii in a teaching hospital from the United States"
Vaze ND, Emery CL, Hamilton RJ, Brooks AD, and Joshi SG
Advances in Infectious Diseases, 3(1):10-16 (2013)
"Nonequilibrium plasma-activated antimicrobial solutions are broad-spectrum and retain their efficacies for extended period of time"
Ercan UK, Wang H, Ji H, Fridman G, Brooks AD, and Joshi SG
Plasma Processes and Polymers, 10(6): 544-555 (2013)
"An analysis of the mechanisms that underlie absorption of botulinum toxin by the inhalation route"
Al-Saleem FH, Ancharski DM, Joshi SG, Elias MD, Singh A, Nasser Z, and Simposn LL
Infection and Immunity, 80(12): 4133-4142 (2012)
"Fulminating septicemia due to persistent pan-resistant community-acquired MBL (IMP1)-positive Acinetobacter baumannii"
Telang NV, Satpute MG, Dhakephalkar PK, Niphadkar KB, and Joshi SG
Indian Journal of Pathology and Microbiology, 54(1): 180-182 (2011)
"Modulation of botulinum toxin-induced changes in neuromuscular function with antibodies directed against recombinant polypeptides or fragments"
Joshi SG, Elias MD, Singh AK, Al-Saleem FH, Ancharski DM, Nasser Z, Takahashi T, and Simpson LL
Neuroscience, 179: 208-222 (2011)
"Non-thermal dielectric-barrier discharge (DBD) plasma-induced inactivation involves oxidative-DNA damage and membrane lipid peroxidation in Escherichia coli"
Joshi SG, Cooper M, Yost A, Paff M, Ercan UK, Fridman G, Friedman G, Fridman A, and Brooks AD
Antimicrobial Agents and Chemotherapy, 52: 1053-1062 (2011)
"Control of methicillin-resistant Staphylococcus aureus (MRSA) in planktonic form and biofilms: a biocidal efficacy study of non-thermal DBD-plasma"
Joshi SG, Paff M, Friedman G, Fridman G, Fridman A, and Brooks AD
American Journal of Infection Control, 38: 293-301 (2010)
"Localization of the sites and characterization of the mechanisms by which anti-light chain antibodies neutralize the actions of the botulinum holotoxin"
Takahashi T, Joshi SG, Al-Saleem FH, Ancharski D, Singh AK, Nisser Z, and Simpson LL
Vaccine, 27: 2616-2624 (2009)
"Rickettsia rickettsii-infection causes apoptotic death of cultured Cerebellar Granular Neurons"
Joshi SG, Kovacs AD
Journal of Medical Microbiology 56: 138-141 (2007)
"An initial assessment of the systemic Pharmacokinetics of Botulinum neurotoxin"
Ravichandran E, Gong Y, Al-saleem F, Ancharski D, Joshi SG, Simpson LL
Journal of Pharmacology & Experimental Therapeutics 318 (3): 1343-1351 (2006)
"The Role of Exoproteases in governing intraneuronal metabolism of Botulinum toxin"
Simpson LL, Maksymowych AB, Kouguchi H, DuBois G, Bora RS, Joshi S
The Protein Journal 24:155-165 (2005)
"NF-kB activation suppresses host cell apoptosis during Rickettsia rickettsii infection via regulatory effects on intracellular localization or levels of apoptogenic and antiapoptotic proteins"
Joshi SG, Francis CW, Silverman DJ, Sahni SK
FEMS Microbiology Letters 234: 333-341 (2004)
"Nuclear factor-kappa B protects against host cell apoptosis during Rickettsia rickettsii infection by inhibiting activation of apical and effector caspases and maintaining mitochondrial integrity"
Joshi SG, Francis CW, Silverman DJ, Sahni SK
Infection and Immunity 71 (7): 4127-4136 (2003)